Recurrent and/or metastatic thyroid cancer: therapeutic options.
Thyroid cancer is relatively rare, accounting for 0.5 - 10 cases per 100,000 individuals per year. Despite their generally favourable prognosis, patients with differentiated thyroid cancer are at risk of tumour recurrence for decades after diagnosis. The optimal management remains controversial even...
Những tác giả chính: | Karavitaki, N, Vlassopoulou, V, Tzanela, M, Tzavara, I, Thalassinos, N |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2002
|
Những quyển sách tương tự
-
Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy.
Bằng: Karavitaki, N, et al.
Được phát hành: (2005) -
Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
Bằng: Tzanela, M, et al.
Được phát hành: (2004) -
Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Bằng: Tzanela, M, et al.
Được phát hành: (2005) -
Novel therapeutic options for recurrent metastatic salivary gland tumors: Review of ongoing clinical trials
Bằng: Avinash Pandey, et al.
Được phát hành: (2018-01-01) -
THERAPEUTIC OPTIONS FOR INVASIVE BREAST CANCER
Bằng: Ganusevich O. N., et al.
Được phát hành: (2019-05-01)